Discovery & Development

Researchers demonstrate how extracellular vesicles derived from mesenchymal stem cells can increase survival chances.

We speak to the 2025 winner of Novo Nordisk and Pioneer Group’s Golden Ticket program.

We speak with Colorcon CEO Simon Tasker about the importance of the patient experience when it comes to medicines.

Discussing the development of trends, treatments, and talent in gene therapy with NewBiologix CEO Igor Fisch.

Ivermectin, Viagra and warfarin; I look at the origins of three popular drugs and the role of serendipity.

Advances in computer simulations allow researchers to look at G protein-coupled receptors in more detail than ever before.

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further.

Biotech Versus the Superbugs: Interviewing Centauri Therapeutics CSO Helen Bright

Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.

Some scientists believe “dark” regions could be the key to understanding the relationship between our genetic makeup and diseases.